The IRONMAN study focuses on men with advanced prostate cancer. Prostate cancer is when cells in the prostate gland grow uncontrollably. The study aims to understand how different treatments are used around the world and their effects. It will include at least 5,000 men from various countries. Men will be tracked for at least five years to see how they respond to treatments. They'll fill out surveys about their health every three months. Doctors will also fill out forms when there's a change in treatment. Blood samples will be collected to study how the disease reacts to different therapies.
- Study lasts for at least five years with regular follow-ups.
- Participants need to be willing to share health information.
- Blood samples and health surveys are part of the study.
Men interested in joining should be 21 or older and have confirmed prostate cancer. They must not have other cancers needing systemic treatment, except for specific cases like skin cancer. This research hopes to find better ways to treat prostate cancer by comparing different countries' practices.